Patients in the REVERSE study receive treatment within 6-12 months of symptoms. The Wills Eye patient is the first to be injected in the RESCUE study. "Hopefully, in this trial, we'll be able to prevent visual loss if we treat people early enough in the process," said trial investigator, Dr. Mark Moster, a neuro-ophthalmologist at Wills Eye ....